iMediSync Revenue

Mental Health Care • 1430 Glencoe Dr, Arcadia, United States • 11-20 Employees

iMediSync revenue & valuation

Annual revenue	$1,368,880
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Mental Health Care industry and current estimated revenues	$4,400,000
Total funding	No funding

Key Contacts at iMediSync

Kody Newman

Director Of Operations

Jason Kim

Management Director

Company overview

Headquarters	1430 Glencoe Dr, Arcadia, California 91006, US
Phone number	+8215334080
Websites	imedisyncamericas.com imedisync.com
NAICS	621112
Keywords	Medical, Biotech, Database, Dementia, Depression, Therapeutic, Cloud, Digital, Diagnosis, Platform, Startup, AI, Anxiety, Adhd, Brain Health, Virtual, EEG, Alzheimers, MCI, Parkinson, Biomarker, Mental, Neurological, HRV, Qeeg, Brain Disorder, Mental Disorder, Coma
Employees	11-20
Socials

iMediSync Email Formats

iMediSync uses 2 email formats. The most common is {first name} (e.g., john@imedisync.com), used 66.7% of the time.

Format	Example	Percentage
{first name}	john@imedisync.com	66.7%
{last name}	doe@imedisync.com	33.3%

About iMediSync

Who is iMediSync? - iMediSync Inc is a AI-driven early detection therapeutic platform for optimal brain health. - iMediSync originated from National Standard Data Center for Korean EEG, Seoul National University which has developed Asia’s first QEEG normative DB with more than 1300 healthy subjects ranging from 4 – 90 years old. - iSyncBrain® (https://isyncbrain.com) is an AI driven analysis cloud platform. It has been registered as a class II medical device by the Korean FDA, and users from more than 30 countries are using the platform. - Our early detection EEG algorithm for aMCI, “iSyncBrain – MCI Classifier” was developed and clinically validated with three Korean university hospitals (sensitivity, specificity >90%). It also got the clearance from Korean FDA as a class II medical device for (different underlying pathology) - iSyncHeart® is an AI cloud-based solution for heart rate variability (HRV). It was launched and has been registered as a class II medical device by the Korean FDA. It has been used for remote ECG monitoring of participants in clinical trials. - iSyncBrain® and iSyncHeart® platform are primarily used by doctors and clinical psychologists for research purposes. And it will be expanded for virtual telemental care by June 2021. - The vision of iMediSync is to develop early detecting biomarkers for challenging neurological disorders such as Parkinson’s disease, TBI, PTSD, ADHD, and Depression.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Director

Employees by Department

iMediSync has 2 employees across 1 departments.

Departments

Number of employees

Funding Data

iMediSync has never raised funding before.

Frequently asked questions

iMediSync is located in 1430 Glencoe Dr, Arcadia, US.

You can reach iMediSync at +8215334080.

iMediSync generates an estimated annual revenue of $1,368,880. This revenue figure reflects the company's market position and business performance in its industry.

iMediSync has an estimated valuation of $4,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

iMediSync has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at iMediSync

Kody Newman

Director Of Operations

Jason Kim

Management Director

4.8

40,000 users